Peter C. Hou/Brigham and Women's Hospital
Aug 8, 2025, 12:37
Auxora in Severe COVID-19: Phase 2 Trial Reveals D-Dimer Reduction Benefits
Thrombosis Update shared an insightful post on X:
“New article in Thrombosis Update. Findings from a phase 2 trial show that Auxora may help patients with severe COVID-19 by reducing D-dimer levels.”
Read the full article here.
Title: Reduction in D-dimer levels after treatment with Auxora in patients with severe COVID-19 pneumonia
Authors: Peter C. Hou, Joseph Miller, Charles Bruen, Fady Youssef, Michael J. Schnaus, Kathyrn Brouillette, Raul Mendoza-Ayala, Jeffrey Zhang, Kenneth Stauderman, Sudarshan Hebbar
Discover the latest advancements in thrombosis and hemostasis research on Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera